- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 7/52 - Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
Patent holdings for IPC class C07K 7/52
Total number of patents in this class: 84
10-year publication summary
|
11
|
8
|
2
|
4
|
7
|
8
|
12
|
6
|
11
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4883 |
4 |
| Enanta Pharmaceuticals, Inc. | 421 |
4 |
| Protagonist Therapeutics, Inc. | 142 |
4 |
| The Procter & Gamble Company | 22165 |
3 |
| Agency for Science, Technology and Research | 3563 |
3 |
| Albany Medical College | 56 |
3 |
| Zealand Pharma A/S | 241 |
3 |
| Genentech, Inc. | 3867 |
2 |
| Ajinomoto Co., Inc. | 2314 |
2 |
| Bracco Imaging S.p.A. | 316 |
2 |
| Brown University | 627 |
2 |
| Regeneron Pharmaceuticals, Inc. | 3978 |
2 |
| Yale University | 2289 |
2 |
| Fog Pharmaceuticals, Inc. | 25 |
2 |
| MSD International GmbH (Singapore Branch) | 5 |
2 |
| Dispersebio Ltd. | 12 |
2 |
| Merck Sharp & Dohme LLC | 3744 |
2 |
| A&J Science Co.,Ltd. | 7 |
2 |
| Merck Sharp & Dohme Corp. | 2219 |
1 |
| Bayer Schering Pharma AG | 430 |
1 |
| Other owners | 36 |